THOMPSON DAVIS & CO., INC. - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 44 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2018$3,000
+200.0%
250
+100.0%
0.01%
+250.0%
Q2 2018$1,0001250.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
BVF INC/IL 1,878,508$12,830,0001.68%
Knoll Capital Management, LLC 210,000$1,434,0001.63%
Vivo Capital, LLC 971,337$6,634,0000.85%
P.A.W. CAPITAL CORP 90,000$615,0000.77%
683 Capital Management, LLC 1,350,000$9,221,0000.56%
Ibex Investors LLC 500,000$3,415,0000.56%
MEITAV INVESTMENT HOUSE LTD 653,667$4,465,0000.28%
FIRST MIDWEST BANK TRUST DIVISION 214,872$1,468,0000.22%
Nantahala Capital Management 834,401$5,699,0000.18%
PREMIER ASSET MANAGEMENT LLC 73,950$505,0000.14%
View complete list of GALMED PHARMACEUTICALS LTD shareholders